沃森生物 (300142)

Walvax Biotechnology Co.,Ltd.

ASZ

Tags

CSI 200 IndexCSI A100 IndexLow Safety ScoreInnovative DrugsGuozheng Growth IndexLarge Cap GrowthEmerging Markets IndexPrivate Enterprises 100 IndexBiological ProductsBiological VaccinesDispersed ShareholdingChiNext InnovationChiNext Large CapChiNext 50 IndexChiNext IndexChiNext Blue ChipChiNext HealthcareChiNext TechShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexTech 100 IndexPharma & BiotechConsumer Services IndexSZSE Medicine Equal Weight IndexSZSE 100 Equal Weight IndexYangtze River Protection IndexMid-cap High Beta IndexZhongchuang Equal Weight IndexCSI Emerging Industries IndexJuchao Large-cap IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexChiNext Equal Weight IndexCSI 100 Low Volatility IndexCSI All-share Pharmaceutical Sector IndexSZSE Emerging Industries IndexZhongchuang Growth IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexCSWD Life Sciences IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexBiomedicine IndexHepatitis B VaccineCOVID-19 VaccineFTSE Russell ConceptShareholding Increase CommitmentLarge-cap Blue-chipAntiviralCSI 300 Non-cyclical IndexCNI Emerging Industries IndexTechnology 50 IndexSmall-cap High Beta IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexVaccine & Biotech IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexSTAR Market & ChiNext 50 IndexSZSE Technology IndexSZSE 100 Return IndexSHS Innovative Drugs IndexSZSE High Beta IndexSZSE ChiNext 100 IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexChiNext Basic IndexSZSE Private Enterprises IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSmart Select 300 ESG Leading IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightCS Biomedicine IndexInnovative Drugs 30 IndexCSI 300 Pharmaceutical IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexPharmaceutical 50 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexPharmaceutical 50 Strategy IndexCSI Life Sciences IndexSZSE 200 Return IndexSZSE 200 IndexYangtze River 100 IndexChiNext Manufacturing IndexZhongchuang 400 IndexCS Innovative Drugs IndexChiNext Growth IndexESG 300 IndexCR New Momentum IndexChiNext Return IndexJuchao Mid-cap IndexSZSE 500 IndexChiNext Emerging IndexCSI 300 Growth Innovation IndexCSI 500 ESG IndexStrategic Emerging Industries 100 Index

K-Line Chart

No K-line data available

Company NameYunnan Walvax Biotechnology Co., Ltd.
Listing Date2010-11-12
Issue Price95RMB
Registered Capital159934.854110k RMB
Legal RepresentativeLi Yunchun
Registered AddressNo. 395 Kexin Road, High-Tech Zone, Kunming City, Yunnan Province
IndustryBiological Products
Main BusinessResearch, production, and sales of vaccine products.
Company ProfileYunnan Walvax Biotechnology Co., Ltd. was founded in 2001. It is a modern biopharmaceutical enterprise in China specializing in the research, development, production, and sales of biological products such as vaccines and blood products. The company is recognized as a National High-Tech Enterprise and a National Enterprise Technology Center. It was listed on the ChiNext Board of the Shenzhen Stock Exchange in November 2010 (Stock Abbreviation: Walvax Biotech; Stock Code: 300142). The company's headquarters is located in Kunming, Yunnan Province, China. It has over 1,200 employees. It possesses a modern R&D center in the Kunming National High-Tech Industrial Development Zone, and has modern vaccine production bases and pilot-scale bases in the Yuxi High-Tech Zone in Yunnan and the China Medical City in Taizhou, Jiangsu. Its marketing network covers over 2,000 counties and districts across 30 provinces and municipalities in China.

Stock Details

1. Key Indicators

  • Total Shares(W): 159934.85
  • Circulating A-Shares(W): 155594.45
  • Earnings Per Share(RMB): 0.1022
  • Net Assets Per Share(RMB): 6.0545
  • Operating Revenue(W RMB): 171880.79
  • Total Profit(W RMB): 13627.86
  • Net Profit Attributable to Parent(W RMB): 16344.29
  • Net Profit Growth Rate(%): -36.24
  • Weighted Return on Equity(%): 1.7200
  • Operating Cash Flow Per Share(RMB): 0.0500
  • Undistributed Profit Per Share(RMB): 1.9861
  • Capital Reserve Per Share(RMB): 2.8442

2. Main Business

The main business covers:

  • Research, development, production, and sales of human vaccines

3. Company Basic Information

  • Company Name: Walvax Biotechnology Co., Ltd.
  • Listing Date: 2010-11-12
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 395 Kexin Road, High-tech Zone, Kunming City, Yunnan Province
  • Website: www.walvax.com
  • Company Profile：The Company was established through the overall change of Walvax Biotechnology Co., Ltd. On June 23, 2009, with the unanimous consent of all shareholders of Walvax Biotechnology Co., Ltd., based on the audited net asset value of RMB 77,626,523.60 as of May 31, 2009 by ShineWing Certified Public Accountants, 75 million shares were converted, and the remaining RMB 2,626,523.60 was included in capital reserve, thus establishing Walvax Biotechnology as a joint-stock company with a registered capital of RMB 75 million. The capital contribution for this overall change was verified by ShineWing Certified Public Accountants in the “XYZH/2007SZA2032-2” Capital Verification Report. On June 25, 2009, the Company obtained the amended business license from the Yunnan Provincial Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 E Fund ChiNext Board ETF Fund 3447.14 2.22
2 Chengdu Xiyun Enterprise Management Partnership (Limited Partnership) General Legal Person 2365.68 1.52
3 CSI 500 ETF Fund 2328.21 1.50
4 China Merchants Guozheng Biopharmaceutical Index Securities Investment Fund (LOF) Class A Fund 2306.78 1.48
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2020.08 1.30
6 Harvest CSI Vaccine and Biotechnology ETF Fund 134.62 0.09
7 ChinaAMC Guozheng Vaccine and Biotech Index Initiation Securities Investment Fund Class A Fund 73.91 0.05
8 Penghua Guozheng Vaccine and Biotech ETF Fund 58.13 0.04
9 Guotai Guozheng Vaccine and Biotech ETF Fund 26.07 0.02
10 China Merchants CSI Vaccine and Biotechnology ETF Fund 11.90 0.01

5. Concept Sectors

  • Biological Vaccine
  • Innovative Drug
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Dispersed Shareholding
  • Low Safety Score
  • ChiNext Index
  • SZSE 300 Index
  • Technology 100 Index
  • ChiNext 300 Index
  • ChiNext Blue Chip Index
  • ChiNext Technology Index
  • ChiNext Pharmaceutical Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information